Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study

Pigment Cell and Melanoma Research

Volumn 22, Issue 3, 2009, Pages 283-295

  Day, Chi Ping ^a   Carter, John ^b   Bonomi, Carrie ^b   Esposito, Dominic ^b   Crise, Bruce ^b   Ortiz Conde, Betty ^b   Hollingshead, Melinda ^c   Merlino, Glenn ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bioluminescence; Cell labeling; Fluorescence activated cell sorter; Green fluorescence protein; Lentiviral vectors; Luciferase; Syngeneic mouse model

Indexed keywords

FERRITIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; LUCIFERASE; RNA POLYMERASE II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL LABELING; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; MELANOMA; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; TRANSGENE;

ANIMALS; DISEASE MODELS, ANIMAL; GENES, REPORTER; GENETIC VECTORS; HUMANS; INDICATORS AND REAGENTS; LENTIVIRUS; MELANOMA; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; TRANSGENES; TUMOR CELLS, CULTURED;

LENTIVIRUS; MAMMALIA; MUS;

EID: 65549101678     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00545.x     Document Type: Article

References (33)

1. Bruening, W., Giasson, B., Mushynski, W. Durham, H.D. (1998). Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter. Nucleic Acids Res. 26, 486 489. (Pubitemid 28291573)
2. Federico, M. (2003). From lentiviruses to lentivirus vectors. Methods Mol. Biol. 229, 3 15.
3. Fidler, I.J. (1975). Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35, 218 224.
4. Follenzi, A., Battaglia, M., Lombardo, A., Annoni, A., Roncarolo, M.G. Naldini, L. (2004). Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103, 3700 3709. (Pubitemid 38596285)
5. Gaggioli, C. Sahai, E. (2007). Melanoma invasion - current knowledge and future directions. Pigment Cell Res. 20, 161 172. (Pubitemid 46776380)
6. Gross, S. Piwnica-Worms, D. (2005). Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7, 5 15. (Pubitemid 40126378)
7. Ha, L., Ichikawa, T., Anver, M. et al. (2007). ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc. Natl. Acad. Sci. U.S.A. 104, 10968 10973. (Pubitemid 47175210)
8. Haas, D.L., Case, S.S., Crooks, G.M. Kohn, D.B. (2000). Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther. 2, 71 80.
9. Hafenrichter, D.G., Wu, X., Rettinger, S.D., Kennedy, S.C., Flye, M.W. Ponder, K.P. (1994). Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 84, 3394 3404. (Pubitemid 24352902)
10. Hanawa, H., Kelly, P.F., Nathwani, A.C., Persons, D.A., Vandergriff, J.A., Hargrove, P., Vanin, E.F. Nienhuis, A.W. (2002). Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther. 5, 242 251. (Pubitemid 34211219)
11. He, J., Yang, Q. Chang, L.J. (2005). Dynamic DNA methylation and histone modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells. J. Virol. 79, 13497 13508. (Pubitemid 41508162)
12. Hoffman, R.M. (2005). The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat. Rev. Cancer 5, 796 806. (Pubitemid 41400779)
13. Hussein, M.R. (2006). Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity. Int. J. Exp. Pathol. 87, 163 176. (Pubitemid 43781682)
14. Khong, H.T. Restifo, N.P. (2002). Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat. Immunol. 3, 999 1005. (Pubitemid 35363649)
15. Kimura, T., Koya, R.C., Anselmi, L. et al. (2007). Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression. Mol Ther. 15, 1390 1399. (Pubitemid 46965335)
16. Klimatcheva, E., Rosenblatt, J.D. Planelles, V. (1999). Lentiviral vectors and gene therapy. Front Biosci. 4, D481 D496.
17. Larue, L. Beermann, F. (2007). Cutaneous melanoma in genetically modified animals. Pigment Cell Res. 20, 485 497. (Pubitemid 47568832)
18. Latta-Mahieu, M., Rolland, M., Caillet, C. et al. (2002). Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression. Hum. Gene Ther. 13, 1611 1620.
19. Little, E., Ramakrishnan, M., Roy, B., Gazit, G. Lee, A.S. (1994). The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 4, 1 18. (Pubitemid 24238439)
20. Liu, H.S., Jan, M.S., Chou, C.K., Chen, P.H. Ke, N.J. (1999). Is green fluorescent protein toxic to the living cells? Biochem. Biophys. Res. Commun. 260, 712 717. (Pubitemid 29371116)
21. Medic, S., Pearce, R.L., Heenan, P.J. Ziman, M. (2007). Molecular markers of circulating melanoma cells. Pigment Cell Res. 20, 80 91. (Pubitemid 46439517)
22. Mutskov, V. Felsenfeld, G. (2004). Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 23, 138 149. (Pubitemid 38165754)
23. O'doherty, U., Swiggard, W.J. Malim, M.H. (2000). Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74, 10074 10080.
24. Persons, D.A., Mehaffey, M.G., Kaleko, M., Nienhuis, A.W. Vanin, E.F. (1998). An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 24, 167 182. (Pubitemid 28365736)
25. Ramanathan, M., Hasko, G. Leibovich, S.J. (2005). Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters: a cautionary tale. Inflammation 29, 94 102. (Pubitemid 44337579)
26. Recio, J.A., Noonan, F.P., Takayama, H., Anver, M.R., Duray, P., Rush, W.L., Lindner, G., De Fabo, E.C., Depinho, R.A. Merlino, G. (2002). Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res. 62, 6724 6730. (Pubitemid 35364144)
27. Rettinger, S.D., Kennedy, S.C., Wu, X., Saylors, R.L., Hafenrichter, D.G., Flye, M.W. Ponder, K.P. (1994). Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. U.S.A. 91, 1460 1464. (Pubitemid 24059032)
28. Sharp, R., Recio, J.A., Jhappan, C. et al. (2002). Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat. Med. 8, 1276 1280. (Pubitemid 35373560)
29. Stripecke, R., Carmen Villacres, M., Skelton, D., Satake, N., Halene, S. Kohn, D. (1999). Immune response to green fluorescent protein: implications for gene therapy. Gene Ther. 6, 1305 1312. (Pubitemid 29359025)
30. Talmadge, J.E., Singh, R.K., Fidler, I.J. Raz, A. (2007). Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am. J. Pathol. 170, 793 804. (Pubitemid 47339349)
31. Ventura, A., Meissner, A., Dillon, C.P., Mcmanus, M., Sharp, P.A., Van Parijs, L., Jaenisch, R. Jacks, T. (2004). Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. U.S.A. 101, 10380 10385. (Pubitemid 38924934)
32. Weber, J.S., Jay, G., Tanaka, K. Rosenberg, S.A. (1987). Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection. J. Exp. Med. 166, 1716 1733. (Pubitemid 18000350)
33. Zaidi, M.R., Day, C.P. Merlino, G. (2008). From UVs to metastases: modeling melanoma initiation and progression in the mouse. J. Invest. Dermatol. 128, 2381 2391.